Evaluation of ONYX in ENDOVASCULAR Treatment of Cerebral AVMs
NCT ID: NCT02180958
Last Updated: 2022-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
140 participants
OBSERVATIONAL
2014-07-31
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
NCT00005902
Treatment of Brain AVMs (TOBAS) Study
NCT02098252
Evolution of Cochleovestibular Schwannomas
NCT04417868
Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma
NCT04859335
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
NCT06014905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* 12 months post last embolization in case of treatment with embolization only
* 12 months after additional treatment with neurosurgery
* 36 months after additional treatment with radiosurgery
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cerebral Arteriovenous Malformations
Adult patients requiring endovascular treatment of Cerebral Arteriovenous Malformations.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient is at least 6 years old.
Exclusion Criteria
* The patient and/or his/her legal representative (if applicable) refuses to give his/her consent to the collection and processing of data required by the centralized follow-up. For patients who refused collection of their personal data, only, the reason for non inclusion and date of implantation will be documented.
* Any condition that could prevent follow-up of the patient.
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Neurovascular Clinical Affairs
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric Ricolfi, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire Dijon
Christophe Cognard, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Laurent Spelle, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Hôpital Bicêtre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Besançon
Besançon, , France
Chu Pellegrin
Bordeaux, , France
CHU Côte de Nacre
Caen, , France
CHU Gabriel Montpied
Clermont-Ferrand, , France
CHI Dijon
Dijon, , France
CHP Clairval
Marseille, , France
Hôpital GUI DE CHAULLAC
Montpellier, , France
CHU Nantes
Nantes, , France
Fondation Ophtamoligique Rothschild
Paris, , France
Groupe Hospitalier Pitier Salpetrière
Paris, , France
Hôpital Beaujon
Paris, , France
Hôpital Bicêtre
Paris, , France
CHU Pontchaillou
Rennes, , France
CHU Strasbourg
Strasbourg, , France
HIA Sainte Anne
Toulon, , France
CHU Toulouse
Toulouse, , France
CHRU Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NV-ONY-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.